Discussant Clifford Hudis, MD, Chief, Breast Medicine Service at Memorial Sloan Kettering Cancer Center, New York, highlighted the obvious clinical advantages of APF530 over the current standard of care. "If this drug were simply the same in price and availability, why wouldn't y
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1TgsUpl
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου